Bausch Health Companies Inc. sell marge
Start price
25.11.15
/
50%
€83.57
Target price
24.12.15
€70.00
Performance (%)
26.24%
End price
24.12.15
€105.50
Summary
This prediction ended on 24.12.15 with a price of €105.50. The prediction closed with a disappointing performance of 26.24%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bausch Health Companies Inc. | 1.239% | 1.239% | -24.310% | -44.086% |
| iShares Core DAX® | -1.779% | 2.475% | 1.471% | 58.088% |
| iShares Nasdaq 100 | 1.522% | 3.290% | 33.721% | 91.613% |
| iShares Nikkei 225® | 1.083% | 7.039% | 59.258% | 78.826% |
| iShares S&P 500 | 0.929% | 3.254% | 24.730% | 70.002% |
Comments by marge for this prediction
In the thread Bausch Health Companies Inc. diskutieren
marge stimmt dem Crowdsentiment von 'Buy' nicht zu
marge stimmt am 25.11.2015 dem Buy-Crowdsentiment mit dem Kursziel 158.45€ überhaupt nicht zu.
Investors believe Valeant's accounting and transparency standards are at
least questionable. Investor confidence, a naturally fragile thing, has
taken such a devastating hit in October and November that a profound
recovery of Valeant Pharmaceuticals' stock price is highly unlikely,
at least in the short-term!
(Vom Mitglied beendet)
Stopped prediction by marge for Bausch Health Companies Inc.
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€16.05
01.01.19
01.01.19
€29.80
04.11.21
04.11.21
45.23%
05.11.21
05.11.21
